ada.enesco, Author at European Medical Journal - Page 15 of 65

Esketamine Reduces Catheter-Related Bladder Discomfort After Ureteroscopy

The present study assessed the efficacy of sub-anaesthetic esketamine for CRBD prevention in patients undergoing ureteroscopic lithotripsy.

New Model Maps Pathways Driving Severe Asthma Exacerbation Risk

A registry-based analysis using Bayesian modelling has mapped the pathways linking biomarkers, lung function, and comorbidities to severe asthma exacerbation risk.

Most Patients with Chronic Pain Stop Medical Cannabis Within a Year, Study Shows

Over half of chronic pain patients discontinue medical cannabis within a year, highlighting need for individualised care.

Gut Microbiota Shapes Immune Pathways in Allergic Asthma

Against this backdrop, the gut–lung axis has emerged as a persuasive framework for understanding disease heterogeneity.

TriCLASP Study Confirms Safety and Symptom Improvement with Transcatheter Tricuspid Repair

TriCLASP study confirms PASCAL T-TEER safely reduces tricuspid regurgitation and improves symptoms and quality of life.

Low Testosterone Linked to Worse Prostate Cancer Outcomes

While MRI performance does not appear to depend on testosterone and inter-reader agreement is high, open questions remain, including whether PSMA PET or genomic markers could further refine early detection.

Is Ultrasound Effective in Diagnosing Steatotic Liver Disease?

Ultrasound is an effective screening tool for steatotic liver disease, provided that inter- and intra-observer comparisons are incorporated to enhance diagnostic consistency.

NIH-NINDS Initiative Unveils Advanced TBI Characterisation System

A multidimensional framework revolutionises traumatic brain injury characterisation, offering more personalised and accurate care.

Does Potato Consumption Increase the Risk of Type 2 Diabetes?

Total potato intake was positively associated with risk of developing Type 2 diabetes, but this effect was primarily driven by intake of French fries.

Dexamethasone Boosts Short-Term Relief in Allergic Rhinitis

Both groups demonstrated significant improvements over pretreatment at every follow-up, one week, one month, three months and six months.